Alphabet will not have to divest its Chrome browser or Android operating system.
Drug trials fail all the time. What is rare is a failure that costs a company tens of billions of dollars in a single afternoon. That is what happened to AstraZeneca (AZN) on July 9. Read more…
Wall Street just sent a clear signal to income investors who count on AT&T for steady payouts. Morgan Stanley slashed its price target on the telecom giant, and the reason has little to do with Read more…
Oracle’s stock performance from the 1980s pushed the tech giant to split its shares. Its fortunes rose and fell during the dot-com era, and then picked up again in recent years with the popularity of Read more…